Vietnam Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Vietnam Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The Vietnam Clinical Nutrition for Diabetes Care Market was valued at $10.75 Mn in 2023 and is predicted to grow at a CAGR of 5.01% from 2023 to 2030, to $15.14 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Abbott Nutrition, Roche Diabetes Care, Sanofi and Novo Nordisk among others.

ID: IN10VNPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: Vietnam AUTHOR: Avantika Gupta

Buy Now

Vietnam Clinical Nutrition for Diabetes Care Market Executive Summary

The Vietnam Clinical Nutrition for Diabetes Care Market is at around $10.75 Mn in 2023 and is projected to reach $15.14 Mn in 2030, exhibiting a CAGR of 5.01% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.
The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Abbott Nutrition, Sanofi is known for its extensive portfolio of medications, including those essential for diabetes care. Nestlé Health Science, Danone Nutricia, and Herbalife Nutrition are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

Vietnam Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Rising Prevalence of Diabetes

Vietnam faces a growing diabetes epidemic. The International Diabetes Federation (IDF) estimates that over 5.4 million adults in Vietnam have diabetes, with a projected increase in the coming years. This growing burden of diabetes is a major driver for the clinical nutrition market in Vietnam and there is an increasing acknowledgment of the value of nutrition therapy in diabetes treatment and the significance of clinical nutrition products and services in improving patient outcomes.

Expansion of Retail Pharmacy Chains

The expansion of retail pharmacy chains in Vietnam has significantly improved distribution channels for clinical nutrition products. These chains offer wider geographical coverage and more consistent stock availability. Consumers now have easier access to diabetes-specific nutritional products in their local areas. Pharmacies also provide a trusted point of purchase, often with trained staff who can offer basic advice on product selection and usage.

Government Initiatives

The Vietnamese government is actively involved in promoting healthy lifestyles and addressing chronic diseases like diabetes. It involves public awareness campaigns to educate people about diabetes risk factors and healthy eating habits, expanding access to diabetes screening and diagnostic services. National Diabetes Prevention and Control Program is an ongoing program focusing on the early detection, treatment, and management of diabetes.

Market Restraints

Expensive Specialized Products

Specialized diabetic food items and enteral feeding formulas can be considerably more expensive than regular groceries. This can be a burden for patients with limited financial resources or inadequate health insurance coverage. It highlights the economic burden associated with the high cost of specialized therapeutic nutrition products in diabetes care.

Accessibility Challenge

The accessibility of clinical nutrition products and services for diabetes care in Vietnam is hindered by the country's underdeveloped healthcare infrastructure, particularly in remote and rural areas. Inadequate healthcare facilities, lack of trained professionals, and poor transportation networks make it difficult for patients in these regions to access specialized nutrition services and obtain necessary products. This geographic barrier limits the reach and utilization of clinical nutrition for diabetes management across Vietnam.

Competition from Traditional Medicine

The widespread use of traditional Vietnamese medicine (TVM) and alternative remedies in Vietnam poses a significant market restraint for clinical nutrition products for diabetes care. Many Vietnamese patients prefer more natural, holistic approaches to healthcare and may be inclined to use traditional herbal medicines. This cultural preference for traditional remedies limits the adoption and growth of the clinical nutrition market in the country.

Regulatory Landscape and Reimbursement Scenario

Vietnam Food Administration (VFA) plays a crucial role in ensuring the safety and quality of food products, including those intended for diabetic diets. To register a clinical nutrition product in Vietnam, manufacturers or importers must submit an application dossier to the Ministry of Health (MOH). The dossier typically includes documents such as a Certificate of Free Sale, product licenses, samples, labels, and a Certificate of Good Manufacturing Practice (GMP). The registration process can take several months, including document preparation, submission and review, laboratory testing, labeling review, and final approval. Vietnam has specific labeling requirements for health supplements, including mandatory information such as the product name, composition, quantity, manufacturing date, usage instructions, shelf life, country of origin, and manufacturer details.

Health insurance coverage in Vietnam has been introduced over 10 years ago, but it is still relatively low. The Vietnam Health Insurance Scheme (VHIS) reimburses 80-100% of the cost of primary services and 40-100% of specialized services. Private insurance plans can vary significantly, with some offering limited coverage for clinical nutrition and others excluding it entirely. Employer-sponsored health plans might have specific coverage policies for diabetes management services, potentially including some aspects of clinical nutrition.

Competitive Landscape

Key Players

Here are some of the major key players in the Vietnam Clinical Nutrition for Diabetes Care Market:

Abbott Nutrition
Nestlé Health Science
Danone Nutricia
Novo Nordisk
Sanofi
Eli Lilly
Roche Diabetes Care
Herbalife Nutrition
Friesland Campina
NutiFood

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Vietnam Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.